Skip to main content
. 2021 Sep 27;12:730320. doi: 10.3389/fimmu.2021.730320

Figure 5.

Figure 5

Forest plot (random-effects model) of the association between ICI rechallenge and ORR or DCR after ICI rechallenge in patients with NSCLC. CI, confidence interval; DCR, disease control rate; ICIs, immune checkpoint inhibitors; irAEs, immune-related adverse events; M-H, Mantel–Haenszel model; NSCLC, non-small cell lung cancer; ORR, objective response rate. The sizes of the squares indicate the weight of the study.